Therapeutic Adherence in Uncontrolled Arterial Hypertension

Status Recruiting

Clinical Trial Summary

In hypertension, highly prevalent, up to 10-15% of hypertensive patients have uncontrolled blood pressure despite being treated with ≥3 drugs, which is known as resistant hypertension. Resistant arterial hypertension, together with difficult-to-control hypertension, has a worse cardiovascular prognosis than controlled hypertension. In addition, data on therapeutic adherence in arterial hypertension show that 1 in 2 hypertensive patients do not fully or partially comply with the indicated therapeutic prescription. The determination of antihypertensive drugs or their metabolites in urine seems to be a good indicator of therapeutic adherence. On the other hand, the implementation of a specific program to improve knowledge of the disease and its risks and promote therapeutic adherence could improve the control of hypertension and reduce the associated morbidity and mortality.

Clinical Trial Description

Objective: To assess whether the implementation of a specific action plan to improve adherence for 3 months results in reduced peripheral 24h-systolic blood pressure (SBP) in patients with resistant hypertension (RH) or uncontrolled hypertension with 2 antihypertensive drugs.

Method: interventional, prospective, randomized, controlled, parallel groups, open study of a cohort of 150 consecutively recruited patients with RH (office SBP ≥140mmHg and/or diastolic blood pressure ≥90mmHg despite treatment with ≥3 drugs at appropriate doses, one diuretic) or patients with uncontrolled hypertension with 2 antihypertensive drugs, with ambulatory 24h-BP ≥130 and / or 80mmHg. The partially or completely non-adherent patients (confirmed by determination of antihypertensive drugs in urine) will be randomized (1: 1) to receive a specific program to improve adherence (intervention group) or routine follow-up (control group), with office BP measurement and determination of antihypertensive drugs in urine at pre-randomization, 3, 6 and 12 months; peripheral and central 24h-ambulatory BP monitoring will be performed at pre-randomization, at 3 and 12 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04464746
Study type	Interventional
Source	Parc de Salut Mar
Contact	Anna Faura, nurse
Phone	0034 93 248 36 89
Email	afaura@parcdesalutmar.cat
Status	Recruiting
Phase	N/A
Start date	July 1, 2018
Completion date	December 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04573465` - Pilot Evaluation of Peer-support Coaching to Increase Adherence to Online Self-help for College Mental Health	N/A
Withdrawn	`NCT05566015` - Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders	N/A
Enrolling by invitation	`NCT06070415` - Adherence to Exercises for Low Back Pain.	N/A
Completed	`NCT04464421` - SMART Effectiveness Trial	N/A
Completed	`NCT04323215` - Evaluation of a Digital Childhood Obesity Treatment
Completed	`NCT06434259` - Evaluation of Long-term Digital Childhood Obesity Treatment
Completed	`NCT05022706` - Pilot Study of a Transition Intervention for ALWH	N/A
Recruiting	`NCT05084625` - PACED-digitized Support During Adjuvant Endocrine Therapy	N/A
Completed	`NCT04377321` - Colchicine Has Anti-diabetic Effect
Enrolling by invitation	`NCT06115538` - Comparison of Dopamin Level in Idiopathic Parkinson's Patients	Phase 4
Completed	`NCT03842384` - Digital Health Intervention to Support Opioid Use Disorder Treatment	N/A
Recruiting	`NCT05869461` - Improving HIV Adherence Care for Key Populations in India	N/A
Active, not recruiting	`NCT04221789` - TB Treatment Support Tool Interactive Mobile App and Direct Adherence Monitoring on TB Treatment Outcomes	N/A
Recruiting	`NCT05825807` - Adherence to Pharmacological Antiepileptic Treatment in Adolescence
Active, not recruiting	`NCT04166617` - Assessment Effectiveness of the Leap Motion Capture® System on the Functionality of the Upper Limb in Acquired Brain Injury	N/A
Active, not recruiting	`NCT04166422` - Virtual Reality and Video Games in Cardiac Rehabilitation Programs	N/A
Completed	`NCT04171908` - Semi-inmersive Virtual Reality on Upper Limb in Multiple Sclerosis	N/A
Completed	`NCT04117750` - Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome	N/A
Enrolling by invitation	`NCT05321641` - Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications	N/A
Active, not recruiting	`NCT05907174` - Siyakhana Peer: Evaluating a Peer Recovery Coach Model to Reduce Substance Use Stigma in South African HIV Care	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.